Track the progress of Metal-Drug Complex formulations through validation, preclinical, and future clinical phases.
| Compound | Indication | Mechanism | Phase | Lead Institution |
|---|---|---|---|---|
| Zn²⁺-Ivermectin | Antiviral | Enhanced protein binding / solubility | Preclinical | Kunfirm Biotech Lab (AZ) |
| Cu²⁺-Histidine | Neuroinflammation | ROS-triggered timed release | Model Validation | Kunfirm + UTexas CEM |
| Ru⁴⁺-Doxorubicin | Oncology | pH-triggered tumor cytotoxicity | In Vitro Active | MDC Core / Independent Studies |
| Bi³⁺-Minocycline | Spinal Trauma / CNS | Neuroprotective coordination | In Design | KT Translational Research |